IFN-γ synergizes with TNF-α to induce RIPK1-independent necroptosis of mesenchymal stem/stromal cells

Author:

Ren Xiang1,Huo Jiali1,Li Xingxin1,Wang Min1,Jin Peng1,Nie Neng1,Zhang Jing1,Huang Jinbo1,Zheng Yizhou1,Ge Meili1

Affiliation:

1. Chinese Academy of Medical Sciences & Peking Union Medical College

Abstract

Abstract

Interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) are two vital inflammatory factors elevated in many diseases. An inflammatory microenvironment is detrimental to residual cells, yet the precise mechanisms of cell impairment are not fully understood. IFN-γ and TNF-α have distinct effects on the immunoregulatory properties of mesenchymal stem/stromal cells (MSCs) and they have been raised to be optimal prime factors to enhance the immunosuppressive capacity of in vitro engineered MSCs. However, controversies remain with regard to the normal function maintenance of cells as they may be impaired after exposure to inflammatory factors. Here, we found that IFN-γ synergises with TNF-α to induce cell dysfunction and death of MSCs via necroptosis. When MSCs were exposed to both IFN-γ and TNF-a, its morphological features and biological functions were injured. Mechanistically revealed by RNA-Sequencing, the injured MSCs undergone a unique cell death process, namely necroptosis. Compared with controls, IFN-γ and TNF-a synergistically increased the expression of RIPK1, RIPK3, MLKL and all other genes associated with necroptosis significantly. Rescue experiments further showed that the process could be reversed by RIPK3 and MLKL inhibitor but RIPK1inhibitor, suggesting a RIPK1-independent pathway and a promising cell preservative approach. Collectively, these results disclose an inflammatory injury mechanism of MSCs, which may shed new light on revealing the MSCs deficits in some inflammation associated diseases with expectations to innovate some potential targeted therapies. In addition, inflammatory impairment should be taken into consideration when delivering cell therapy based on MSCs primed with IFN-γ and TNF-α.

Publisher

Research Square Platform LLC

Reference48 articles.

1. Multilineage potential of adult human mesenchymal stem cells;Pittenger MF;Science,1999

2. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici M;Cytotherapy,2006

3. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk;Fattizzo B;Int J Mol Sci,2020

4. Nasri A, Foisset F, Ahmed E, Lahmar Z, Vachier I, Jorgensen C, et al. Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease. Cells-Basel. 2021;10.

5. The Clinical Trials of Mesenchymal Stromal Cells Therapy;Kouchakian MR;Stem Cells Int,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3